Ambulatory BP Monitors TM-2441 A&D
Product description:
The new TM-2441 and TM-2440 are created expressly for purpose, unlike some less deliberately made ambulatory devices that are bulky, unwieldy, and unpleasant, and are based on standard desktop/home use type monitors.
Weight: When it comes to patient comfort and receiving the best results, the weight of an ambulatory monitor is a key aspect. The new A&D series is the lightest in this class, with the TM-2440 weighing only 122 grams and the more feature-rich TM-2441 weighing only 135 grams.
This ensures that your patient will be oblivious to the fact that they are wearing an A&D Ambulatory Monitor.
Compact Design: When it comes to picking a device that a patient can wear comfortably and discreetly for long periods of time, the size of an Ambulatory Monitor is another significant consideration.
The new TM-2441 and TM-2440 are the smallest in their class, with dimensions of only 66mm x 24.5mm x 95mm (WxHxD). This, once again, ensures that your patient is barely aware that they are wearing an A&D Ambulatory Monitor.
Soft cloth cuff: Unlike some previous devices, which have rough plastic cuffs, the TM-2441 and TM-2440 have a soft, machine washable material that ensures optimal comfort as the patient wears the device for extended periods of time.
Upper Arm fittings range from 15cm to 45cm in the cuff range.
AFib+ : A&D pioneered IHB (Irregular Heart Beat)/Circadian Rhythm analysis technology in 2001, and this technology has been further improved on the new Ambulatory Monitor line.
The new monitors are equipped with A&D’s revolutionary Afib+ technology, which allows patients to be screened for both irregular heartbeat and atrial fibrillation (AFib).
PatientView 360: The new TM-2441 offers Clinicians a complete and comprehensive multi-sensor monitoring solution, enabling for the tracking and recording of extra patient-centric data while the device is worn.
By capturing Activity, Temperature, and Air Pressure in addition to blood pressure and heart rate, the new TM-2441 gives clinicians a more complete picture of the patient, allowing them to make better therapeutic judgments.
Waveform data recording and display
The TM2441 series uses an oscillometric waveform to record blood pressure. You may inspect the waveform record for each measurement using our new analysis software. Determine the precision of measured values quickly.
Connectivity: The new A&D ABPM line has USB and BLE (Bluetooth Low Energy/Bluetooth Smart) connectivity as standard. This gives you more freedom and makes data transmission to EPR systems much easier.
Secure threaded cuff connection: Unlike some previous ABPMs with a push-in connector, both the TM-2441 and TM-2440 offer a secure thread-locking connection. This ensures that the cuff does not detach from the device while the patient is using it in ordinary life, and that the patient’s readings are not lost or erroneous.
All-in-one monitoring solution: The new TM-2441 gives clinicians and patients maximum flexibility by measuring and monitoring blood pressure in ambulatory (ABPM), home (HBPM), office (OBP), automatic night blood pressure (ANBP), and automatic self blood pressure (ASBP).
The importance of ABPM in hypertension management has been recognized in hypertension guidelines, and a number of authoritative groups have now produced ABPM use guidelines. A taskforce of participants at the International Society of Hypertension’s 1999 Consensus Conference on ABP Monitoring advised that:
‘ABPM should only be used as an adjunct to traditional BP [blood pressure] measurement using adequately certified equipment. The use of ABPM for screening purposes is not advised because it necessitates a significant investment in equipment and training.
White-coat hypertension (WCH), also known as isolated clinic hypertension, is most easily identified using ABPM. The use of ABPM or related approaches for tracing the white-coat effect should become standard diagnostic and therapeutic procedures for both treated and untreated individuals with high clinic blood pressures.Long-term outcome trials should help to better establish the benefits of incorporating ABPM as an adjunct to conventional sphygmomanometry in the routine care of hypertension patients, as well as provide more precise information on long-term cost-effectiveness.’
Reviews
There are no reviews yet.